Envision Healthcare
EVHC
Delayed Nyse - 06/27 10:03:22 pm
62.67USD
+0.74%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Sales3 6967 948
EBITDA6311 075
Operating profit (EBIT)568938
Pre-Tax Profit (EBT)--
Net income-27,721,3
EPS ( $ )-0,470,07
Dividend per Share ( $ )--
Yield--
Announcement Date02/28/2017
09:15pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Debt5 5075 470
Finance--
Operating income (EBITDA)6311 075
Leverage
(Debt/EBITDA)
8,73x5,09x
Capital Expenditure99,5132
Book Value Per Share (BVPS)57,3 $55,1 $
Cash Flow per Share6,66 $5,26 $
Announcement Date02/28/2017
09:15pm
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 7 312 M$ -
Entreprise Value (EV) 12 781 M$ 12 040 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 900x 19,8x
Capitalization / Revenue 0,92x 0,82x
EV / Revenue 1,61x 1,35x
EV / EBITDA 11,9x 10,0x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 1,13x 1,08x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 11,8% 12,0%
operating Leverage (Delta EBIT / Delta Sales) 0,57x 1,17x
Net Margin (Net Profit / Revenue) 0,27% 4,25%
ROA (Net Profit / Asset) 2,60% 3,20%
ROE (Net Profit / Equities) 6,45% 7,66%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,66% 1,09%
Cash Flow / Sales 7,78% 9,51%
Capital Intensity (Assets / Sales) 0,10x 1,33x
Financial Leverage (Net Debt / EBITDA) 5,09x 3,94x
Price Earning Ratio
BNA & Dividende